MAPT and Apathy: Other studies have identified tau proteins in the orbitofrontal cortex as potential contributors to focal neurotoxicity in the orbitofrontal cortex, which in turn disrupts the orbitofrontal cortex-leptomeningeal bundle network, leading to the emergence and progression of apathy in AD patients.